This Article Figures Only Full Text Full Text (PDF) View Trial Investigators Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (65) Citing Articles via Google Scholar Google Scholar Articles by Patti, G. Articles by Di Sciascio, G. Search for Related Content PubMed PubMed Citation Articles by Patti, G. Articles by Di Sciascio, G.

LATE-BREAKING CLINICAL TRIAL

Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention

Results of the ARMYDA-ACS Randomized Trial

Giuseppe Patti, MD, FACC^_*, Vincenzo Pasceri, MD, PhD, FACC, Giuseppe Colonna, MD, Marco Miglionico, MD^_*, Dionigi Fischetti, MD, Gennaro Sardella, MD, FACC, Antonio Montinaro, MD and Germano Di Sciascio, MD, FACC, FESC^_*,_*

^_* Department of Cardiovascular Sciences, Campus Bio-Medico University, Rome, Italy
Interventional Cardiology Unit, San Filippo Neri Hospital, Rome, Italy
Interventional Cardiology Unit, Vito Fazzi Hospital, Lecce, Italy
Department of Cardiovascular and Respiratory Sciences, La Sapienza University, Rome, Italy.

Manuscript received February 10, 2007; revised manuscript received February 23, 2007, accepted February 23, 2007.

^_* Reprint requests and correspondence: Dr. Germano Di Sciascio, Department of Cardiovascular Sciences, Campus Bio-Medico University, Via E. Longoni 83, 00155 Rome, Italy. (Email: g.disciascio{at}unicampus.it).

Objectives: This study sought to investigate potential protective effects of atorvastatin in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI).

Background: Randomized studies have shown that pretreatment with atorvastatin may reduce periprocedural myocardial infarction in patients with stable angina during elective PCI; however, this therapy has not been tested in patients with ACS.

Methods: A total of 171 patients with non–ST-segment elevation ACS were randomized to pretreatment with atorvastatin (80 mg 12 h before PCI, with a further 40-mg preprocedure dose [n = 86]) or placebo (n = 85). All patients were given a clopidogrel 600-mg loading dose. All patients received long-term atorvastatin treatment thereafter (40 mg/day). The main end point of the trial was a 30-day incidence of major adverse cardiac events (death, myocardial infarction, or unplanned revascularization).

Results: The primary end point occurred in 5% of patients in the atorvastatin arm and in 17% of those in the placebo arm (p = 0.01); this difference was mostly driven by reduction of myocardial infarction incidence (5% vs. 15%; p = 0.04). Postprocedural elevation of creatine kinase-MB and troponin-I was also significantly lower in the atorvastatin group (7% vs. 27%, p = 0.001 and 41% vs. 58%, p = 0.039, respectively). At multivariable analysis, pretreatment with atorvastatin conferred an 88% risk reduction of 30-day major adverse cardiac events (odds ratio 0.12, 95% confidence interval 0.05 to 0.50; p = 0.004).

Conclusions: The ARMYDA-ACS trial indicates that even short-term pretreatment with atorvastatin may improve outcomes in patients with ACS undergoing early invasive strategy. These findings may support routine use of high-dose statins before intervention in patients with ACS.

Abbreviations and Acronyms   CRP = C-reactive protein   MACE = major adverse cardiac event   PCI = percutaneous coronary intervention

This article has been cited by other articles:

				G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, S. M. Hollenberg, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J. Am. Coll. Cardiol., December 6, 2011; 58(24): e44 - e122. [Full Text] [PDF]

				G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, S. M. Hollenberg, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J. Am. Coll. Cardiol., December 6, 2011; 58(24): 2550 - 2583. [Full Text] [PDF]

				Writing Committee Members, G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation, December 6, 2011; 124(23): e574 - e651. [Full Text] [PDF]

				Writing Committee Members, G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation, December 6, 2011; 124(23): 2574 - 2609. [Full Text] [PDF]

				R. Tuuminen, S. Syrjala, R. Krebs, M. A. I. Keranen, K. Koli, U. Abo-Ramadan, P. J. Neuvonen, J. M. Tikkanen, A. I. Nykanen, and K. B. Lemstrom Donor Simvastatin Treatment Abolishes Rat Cardiac Allograft Ischemia/Reperfusion Injury and Chronic Rejection Through Microvascular Protection Circulation, September 6, 2011; 124(10): 1138 - 1150. [Abstract] [Full Text] [PDF]

				N. Katsiki, V. G. Athyros, and D. P. Mikhailidis Does Metabolic Syndrome Influence Outcome Following Percutaneous Coronary Intervention? Angiology, August 1, 2011; 62(6): 437 - 439. [PDF]

				D. T. Ko, H. C. Wijeysundera, L. Yun, P. C. Austin, W. J. Cantor, and J. V. Tu Effectiveness of Preprocedural Statin Therapy on Clinical Outcomes for Patients With Stable Coronary Artery Disease After Percutaneous Coronary Interventions Circ Cardiovasc Qual Outcomes, July 1, 2011; 4(4): 459 - 466. [Abstract] [Full Text] [PDF]

				C. W. Lee, C.-S. Park, I. Hwang, Y. Kim, D.-W. Park, S.-J. Kang, S.-H. Lee, Y.-H. Kim, S.-W. Park, and S.-J. Park Expression of HMG-CoA reductase in human coronary atherosclerotic plaques and relationship to plaque destabilisation Heart, May 1, 2011; 97(9): 715 - 720. [Abstract] [Full Text] [PDF]

				G. Patti, C. P. Cannon, S. A. Murphy, S. Mega, V. Pasceri, C. Briguori, A. Colombo, K. H. Yun, M. H. Jeong, J.-S. Kim, et al. Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention: A Collaborative Patient-Level Meta-Analysis of 13 Randomized Studies Circulation, April 19, 2011; 123(15): 1622 - 1632. [Abstract] [Full Text] [PDF]

				G. Ganesha Babu, J. Malcolm Walker, D. M. Yellon, and D. J. Hausenloy Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection Eur. Heart J., January 1, 2011; 32(1): 23 - 31. [Abstract] [Full Text] [PDF]

				J.-C. Tardif, P. L. L'Allier, J. Gregoire, R. Ibrahim, G. McFadden, W. Kostuk, M. Knudtson, M. Labinaz, R. Waksman, C. J. Pepine, et al. A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Circ Cardiovasc Interv, December 1, 2010; 3(6): 543 - 548. [Abstract] [Full Text] [PDF]

				R. E. O'Connor, W. Brady, S. C. Brooks, D. Diercks, J. Egan, C. Ghaemmaghami, V. Menon, B. J. O'Neil, A. H. Travers, and D. Yannopoulos Part 10: Acute Coronary Syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Circulation, November 2, 2010; 122(18_suppl_3): S787 - S817. [Full Text] [PDF]

				R. E. O'Connor, L. Bossaert, H.-R. Arntz, S. C. Brooks, D. Diercks, G. Feitosa-Filho, J. P. Nolan, T. L. V. Hoek, D. L. Walters, A. Wong, et al. Part 9: Acute Coronary Syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Circulation, October 19, 2010; 122(16_suppl_2): S422 - S465. [Full Text] [PDF]

				P. Meijer, C. W. Wouters, P. H. H. van den Broek, M. de Rooij, G. J. Scheffer, P. Smits, and G. A. Rongen Upregulation of Ecto-5'-Nucleotidase by Rosuvastatin Increases the Vasodilator Response to Ischemia Hypertension, October 1, 2010; 56(4): 722 - 727. [Abstract] [Full Text] [PDF]

				K. A. Eagle and V. Chopra Statins Before Coronary Procedures: A New Indication for an Old Friend J. Am. Coll. Cardiol., September 28, 2010; 56(14): 1110 - 1112. [Full Text] [PDF]

				D. E. Winchester, X. Wen, L. Xie, and A. A. Bavry Evidence of Pre-Procedural Statin Therapy: A Meta-Analysis of Randomized Trials J. Am. Coll. Cardiol., September 28, 2010; 56(14): 1099 - 1109. [Abstract] [Full Text] [PDF]

				G. Di Sciascio, G. Patti, V. Pasceri, L. Gatto, G. Colonna, A. Montinaro, and on behalf of the ARMYDA-5 PRELOAD Investigators Effectiveness of In-Laboratory High-Dose Clopidogrel Loading Versus Routine Pre-Load in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Randomized Trial J. Am. Coll. Cardiol., August 10, 2010; 56(7): 550 - 557. [Abstract] [Full Text] [PDF]

				E. W. Kuhn, O. J. Liakopoulos, M. J. Borys, P. L. Haldenwang, J. T. Strauch, N. Madershahian, Y.-H. Choi, and T. Wahlers Statins improve surgical ablation outcomes for atrial fibrillation in patients undergoing concomitant cardiac surgery Interact CardioVasc Thorac Surg, July 1, 2010; 11(1): 24 - 29. [Abstract] [Full Text] [PDF]

				M. J. Price, A. Kalyanasundaram, and P. B. Berger The Evidence Base for Platelet Function Testing in Patients Undergoing Percutaneous Coronary Intervention Circ Cardiovasc Interv, June 1, 2010; 3(3): 277 - 283. [Full Text] [PDF]

				G. Di Sciascio, G. Patti, V. Pasceri, G. Colonna, F. Mangiacapra, A. Montinaro, and on behalf of the ARMYDA-4 RELOAD Investigators Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial Eur. Heart J., June 1, 2010; 31(11): 1337 - 1343. [Abstract] [Full Text] [PDF]

				M. Puato, E. Faggin, M. Rattazzi, A. Zambon, F. Cipollone, F. Grego, L. Ganassin, M. Plebani, A. Mezzetti, and P. Pauletto Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques: A Comparison of a Nonstatin-Based Regimen in Patients Undergoing Carotid Endarterectomy Stroke, June 1, 2010; 41(6): 1163 - 1168. [Abstract] [Full Text] [PDF]

				J.-S. Kim, J. Kim, D. Choi, C. J. Lee, S. H. Lee, Y.-G. Ko, M.-K. Hong, B.-K. Kim, S. J. Oh, D. W. Jeon, et al. Efficacy of High-Dose Atorvastatin Loading Before Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: The STATIN STEMI Trial J. Am. Coll. Cardiol. Intv., March 1, 2010; 3(3): 332 - 339. [Abstract] [Full Text] [PDF]

				C. J. Lavie and R. V. Milani High-Dose Atorvastatin in Acute Coronary and Cerebrovascular Syndromes J. Am. Coll. Cardiol. Intv., March 1, 2010; 3(3): 340 - 342. [Full Text] [PDF]

				K. I. Paraskevas, E. Anastasakis, M. Andrikopoulou, and D. P. Mikhailidis Radial Artery Catheterization for Percutaneous Vascular or Coronary Interventions: An Innocent Procedure? Angiology, February 1, 2010; 61(1): 5 - 7. [PDF]

				S. Achenbach and J. Ludwig Is CT the Better Angiogram?: Coronary Interventions and CT Imaging J. Am. Coll. Cardiol. Img., January 1, 2010; 3(1): 29 - 31. [Full Text] [PDF]

				R. Klingenberg and G. K. Hansson Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies Eur. Heart J., December 1, 2009; 30(23): 2838 - 2844. [Abstract] [Full Text] [PDF]

				S. Tsimikas High-Dose Statins Prior to Percutaneous Coronary Intervention: A Paradigm Shift to Influence Clinical Outcomes in the Cardiac Catheterization Laboratory J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2164 - 2166. [Full Text] [PDF]

				G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel Coronary Microembolization: From Bedside to Bench and Back to Bedside Circulation, November 3, 2009; 120(18): 1822 - 1836. [Abstract] [Full Text] [PDF]

				R. Eldor and I. Raz American Diabetes Association Indications for Statins in Diabetes: Is there evidence? Diabetes Care, November 1, 2009; 32(suppl_2): S384 - S391. [Full Text] [PDF]

				C. Obi, W. Wysokinski, K. Karnicki, W. G. Owen, and R. D. McBane II Inhibition of Platelet-Rich Arterial Thrombus In Vivo: Acute Antithrombotic Effect of Intravenous HMG-CoA Reductase Therapy Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1271 - 1276. [Abstract] [Full Text] [PDF]

				A Kumar and D H Roberts Immediate versus deferred coronary angioplasty in non-ST-elevation acute coronary syndromes Heart, September 1, 2009; 95(17): 1455 - 1456. [Full Text] [PDF]

				S. G. Ellis and S. Anwaruddin Recapturing the Magic: Revisiting the Pleiotropic Effects of Statins in Percutaneous Coronary Revascularization J. Am. Coll. Cardiol., August 4, 2009; 54(6): 566 - 568. [Full Text] [PDF]

				G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, and A. Montinaro Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial J. Am. Coll. Cardiol., August 4, 2009; 54(6): 558 - 565. [Abstract] [Full Text] [PDF]

				P. Meijer, W. J.G. Oyen, D. Dekker, P. H.H. van den Broek, C. W. Wouters, O. C. Boerman, G. J. Scheffer, P. Smits, and G. A. Rongen Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo: A New Perspective on Cardiovascular Protection Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 963 - 968. [Abstract] [Full Text] [PDF]

				G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) Study J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1128 - 1133. [Abstract] [Full Text] [PDF]

				A. Abbate, M. C. Kontos, and G. G.L. Biondi-Zoccai No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction Eur. Heart J., August 1, 2008; 29(15): 1795 - 1797. [Full Text] [PDF]

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2355 - 2369. [Full Text] [PDF]

				D. J. Kereiakes, M. A. Turco, J. Breall, N. Z. Farhat, R. L. Feldman, B. McLaurin, J. J. Popma, L. Mauri, P. Zimetbaum, J. Massaro, et al. A Novel Filter-Based Distal Embolic Protection Device for Percutaneous Intervention of Saphenous Vein Graft Lesions: Results of the AMEthyst Randomized Controlled Trial J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 248 - 257. [Abstract] [Full Text] [PDF]

				A. Nusca, R. Melfi, and G. Di Sciascio Review: Percutaneous coronary interventions and statins therapy Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 101 - 107. [Abstract] [PDF]

				D.C. Suh, J.K. Kim, J.W. Choi, B.S. Choi, H.W. Pyun, Y.J. Choi, M.-H. Kim, H.R. Yang, H.I. Ha, S.J. Kim, et al. Intracranial Stenting of Severe Symptomatic Intracranial Stenosis: Results of 100 Consecutive Patients AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 781 - 785. [Abstract] [Full Text] [PDF]

				M. Nahrendorf, D. Sosnovik, J. W. Chen, P. Panizzi, J.-L. Figueiredo, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury Circulation, March 4, 2008; 117(9): 1153 - 1160. [Abstract] [Full Text] [PDF]

				A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al. Highlights of the Year in JACC 2007 J. Am. Coll. Cardiol., January 29, 2008; 51(4): 490 - 512. [Full Text] [PDF]

				R. P. Giugliano and E. Braunwald The Year in Non ST-Segment Elevation Acute Coronary Syndrome J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1386 - 1395. [Full Text] [PDF]

				W. D Cahoon Jr and M. A Crouch Preprocedural Statin Therapy in Percutaneous Coronary Intervention Ann. Pharmacother., October 1, 2007; 41(10): 1687 - 1693. [Abstract] [Full Text] [PDF]

				Atorvastatin Before PCI Benefits ACS Patients Journal Watch Cardiology, May 9, 2007; 2007(509): 4 - 4. [Full Text]

				A. S Wierzbicki Voodoo medicine -- cardiovascular trials jinxed in New Orleans: Dr Anthony Wierzbicki discusses highlights of the 56th Annual Scientific Session of American College of Cardiology held at Morial Conventions Centre in New Orleans March 24th--27th, 2007 The British Journal of Diabetes & Vascular Disease, May 1, 2007; 7(3): 142 - 144. [PDF]